It is being revealed that the more severe the damage of the endothelial glycocalyx (EG) layer, the more likely it is that the prognosis of the patients is poor. For that reason, research is being actively conducted on methods for reducing damage and promoting recovery of the EG layer.The natural regeneration process of the EG layer is up to 7 days. Considering the fact that it is quiet slow, reducing the damage of EG layer is considered to be very important for improving the prognosis of patients undergoing surgery, but there is no clinically proven method. One of the ways receiving attention to reduce damage of EG layer is to stabilize the layer through fluid therapy with albumin. The purpose of this study is to compare the protective effect of the EG layer according to the type of fluid (balanced crystalloid solution vs. 5% albumin) during surgery in patients undergoing off-pump coronary artery bypass surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
106
The group receiving balanced crystalloid solution (Plasma solution-A injection, CJ Pharma, South Korea) during surgery
The group receiving 5% albumin (Albumin 5% inj, Green cross, South Korea) during surgery
Division of Cardiac Anesthesiology, Department of Anesthesiology and Pain Medicine, Cardiovascular Hospital, Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea
Plasma concentration of Syndecan-1
The investigators compare the protective effect of EG layer according to the type of fluid used during surgery in patients undergoing off-pump coronary artery bypass surgery. (Comparison of the plasma concentration of Syndecan-1 between the two groups.)
Time frame: Before induction of anesthesia (1-hour before the start of surgery)
Plasma concentration of Syndecan-1
The investigators compare the protective effect of EG layer according to the type of fluid used during surgery in patients undergoing off-pump coronary artery bypass surgery. (Comparison of the plasma concentration of Syndecan-1 between the two groups.)
Time frame: At the time of returning the heart in place after coronary artery anastomoses (1~2 hour before the end of surgery)
Plasma concentration of Syndecan-1
The investigators compare the protective effect of EG layer according to the type of fluid used during surgery in patients undergoing off-pump coronary artery bypass surgery. (Comparison of the plasma concentration of Syndecan-1 between the two groups.)
Time frame: At the time of sternum being closed (30min~1hr before the end of surgery)
Plasma concentration of Haparan sulfate
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: Before induction of anesthesia (1hr before the start of surgery)
Plasma concentration of Haparan sulfate
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: At the time of returning the heart in place after coronary artery anastomoses (1~2hr before the end of surgery)
Plasma concentration of Haparan sulfate
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: At the time of sternum being closed (30min~1hr before the end of surgery)
Plasma concentration of ANP
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: Before induction of anesthesia (1hr before the start of surgery)
Plasma concentration of ANP
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: At the time of returning the heart in place after coronary artery anastomoses (1~2hr before the end of surgery)
Plasma concentration of TNF-α/IL-6
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: Before induction of anesthesia (1hr before the start of surgery)
Plasma concentration of TNF-α/IL-6
Heparan sulfate is one of the indicators of EG damage, and ANP \& TNF-α, IL-6 are known to correlate with EG damage. So in this study, the investigators measure the plasma concentrations of Haparan sulfate, ANP \& TNF-α, IL-6 as well as Syndecan-1, and also identify the overall short-term prognosis of the patients.
Time frame: At the time of sternum being closed (30min~1hr before the end of surgery)
Composite rate of morbidity and mortality
Composite morbidity and mortality (Mortality, Stroke, Re-operation, Sternal infection, Prolonged ventilation, Renal dysfunction)
Time frame: If the hospitalization period is within 30 days, follow-up is done up to 30 days.
Composite rate of morbidity and mortality
Composite morbidity and mortality (Mortality, Stroke, Re-operation, Sternal infection, Prolonged ventilation, Renal dysfunction)
Time frame: If the hospitalization period exceeds 30 days, follow-up is done throughout the hospitalization period.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.